Log In
BCIQ
Print this Print this
 

Low-dose ITI-007 (ITI-007)

Also known as: formerly ITI-722

  Manage Alerts
Collapse Summary General Information
Company Intra-Cellular Therapies Inc.
DescriptionLow-dose ITI-007, a dual serotonin (5-HT2A) receptor antagonist and dopamine receptor phosphoprotein modulator (DPPM)
Molecular Target Serotonin (5-HT2A) receptor ; Dopamine D2 receptor
Mechanism of ActionSerotonin (5-HT2A) receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today